Killen discusses NIAID strategy, progress in HIV vaccine research and development. National Institute of Allergy and Infectious Diseases.
Killen
J
J
D016915:AIDS Vaccines / Q000592:standards / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015195:Drug Design; D006678:HIV / Q000235:genetics / Q000276:immunology; D009316:National Institutes of Health (U.S.); D016730:Program Development; D012106:Research; D013045:Species Specificity; D014481:United States
D016915:AIDS Vaccines